Cite

HARVARD Citation

    Oosting, S. et al. (n.d.). 2863 A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer. European journal of cancer. pp. S577-. [Online]. 
  
Back to record